Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This is an open-label pilot study evaluating the safety and preliminary evidence of a
therapeutic effect of ODSH (2-0, 3-0 desulfated heparin) in conjunction with standard
induction and consolidation therapy for acute myeloid leukemia.